The Epidemiological Features of Lymphoid Malignancies in Benin City, Nigeria: a 15 Years Study

Overview

Journal Pan Afr Med J

Date 2012 Feb 28

PMID 22368753

Citations 7

Authors

Caroline Edijana Omoti

Alexander Ikenna Nwannadi

Jude Chike Obieche

Adesuwa Noma Olu-Eddo

Affiliations

Soon will be listed here.

Abstract

Introduction: Lymphoid malignancies compose a wide spectrum of different morphologic and clinical syndromes known to vary widely throughout the world. The purpose of this study is to determine the prevalence and time trends of lymphoid malignancies.

Methods: A 15 (May 1st 1996-April 30th 2010) years study of all patients who had lymph node biopsy at the Department of Haematology and Pathology, University of Benin Teaching Hospital, Benin City, Nigeria.

Results: The 391 patients had a male preponderance (M:F; 1.6:1). An increase in the lymphoid malignant cases was noted from 95 cases in the first 5-year interval (1996-2000) to 179 cases in the last 5-year interval (2006-2010) giving an average increase of 84.0%. Non-Hodgkins lymphoma (61.1%) and chronic lymphocytic leukaemia (18.2%) were the most frequent followed by Hodgkin's lymphoma and myeloma with equal proportions of 9.0% each. A positive correlation with a significant linear trends was obtained (r=0.1949, p<0.0001). Geographic areas at risk were found mainly in patients residing in Delta State (67.0%) which is a major oil producing state and Edo State (30.4%) where the hospital is located, both in the Niger Delta Region of Nigeria.

Conclusion: Future research into environmental agents and genetic makeup/HLA typing of patients can be carried out.

Citing Articles

Assessment of Treatment Outcomes and Associated Factors Among Pediatric Patients With Burkitt Lymphoma at Kenyatta National Hospital.

Toor D, Degu A, Karimi P Cancer Rep (Hoboken). 2025; 8(1):e70112.

PMID: 39806864 PMC: 11729749. DOI: 10.1002/cnr2.70112.

Demographic pattern of chronic lymphocytic leukemia in a tertiary hospital in Calabar, South-South Nigeria.

Akaba K, Enang O, Igwilo H, Eduve V, Akaba E, Cletus O Ann Afr Med. 2020; 19(3):203-206.

PMID: 32820734 PMC: 7694702. DOI: 10.4103/aam.aam_60_19.

Presenting features and treatment outcomes of chronic lymphocytic leukaemia in a resource poor Southern Nigeria.

Madu A, Korubo K, Okoye A, Ajuba I, Duru A, Ugwu A Malawi Med J. 2019; 31(2):144-149.

PMID: 31452848 PMC: 6698622. DOI: 10.4314/mmj.v31i2.7.

Ageing, exposure to pollution, and interactions between climate change and local seasons as oxidant conditions predicting incident hematologic malignancy at KINSHASA University clinics, Democratic Republic of CONGO (DRC).

Nganga Nkanga M, Longo-Mbenza B, Adeniyi O, Bikaula Ngwidiwo J, Katawandja A, Kazadi P BMC Cancer. 2017; 17(1):559.

PMID: 28835214 PMC: 5569529. DOI: 10.1186/s12885-017-3547-3.

Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.

Elidrissi Errahhali M, Elidrissi Errahhali M, Boulouiz R, Ouarzane M, Bellaoui M BMC Cancer. 2016; 16:159.

PMID: 26915519 PMC: 4768409. DOI: 10.1186/s12885-016-2205-5.

References

Fisher S, Fisher R . The epidemiology of non-Hodgkin's lymphoma. Oncogene. 2004; 23(38):6524-34. DOI: 10.1038/sj.onc.1207843. View

Bennett J, Catovsky D, Daniel M, Flandrin G, GALTON D, Gralnick H . Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976; 33(4):451-8. DOI: 10.1111/j.1365-2141.1976.tb03563.x. View

Cartwright R, Gurney K, Moorman A . Sex ratios and the risks of haematological malignancies. Br J Haematol. 2002; 118(4):1071-7. DOI: 10.1046/j.1365-2141.2002.03750.x. View

Melo J, Catovsky D, GALTON D . The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol. 1986; 63(2):377-87. View

Rogena E, De Falco G, Schurfeld K, Leoncini L . A review of the trends of lymphomas in the equatorial belt of Africa. Hematol Oncol. 2011; 29(3):111-5. DOI: 10.1002/hon.977. View

Weisenburger D . Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic. Ann Oncol. 1994; 5 Suppl 1:19-24. DOI: 10.1093/annonc/5.suppl_1.s19. View

Cheson B, Bennett J, Rai K, Grever M, Kay N, Schiffer C . Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am J Hematol. 1988; 29(3):152-63. DOI: 10.1002/ajh.2830290307. View

Intragumtornchai T, Wannakrairoj P, Chaimongkol B, Bhoopat L, Lekhakula A, Thamprasit T . Non-Hodgkin's lymphomas in Thailand. A retrospective pathologic and clinical analysis of 1391 cases. Cancer. 1996; 78(8):1813-9. View

Kinlen L, Hudson C, Stiller C . Contacts between adults as evidence for an infective origin of childhood leukaemia: an explanation for the excess near nuclear establishments in west Berkshire?. Br J Cancer. 1991; 64(3):549-54. PMC: 1977635. DOI: 10.1038/bjc.1991.348. View

10.

Meremikwu M, Ehiri J, Nkanga D, Udoh E, Ikpatt O, Alaje E . Socioeconomic constraints to effective management of Burkitt's lymphoma in south-eastern Nigeria. Trop Med Int Health. 2005; 10(1):92-8. DOI: 10.1111/j.1365-3156.2004.01348.x. View

11.

Groves F, Linet M, Devesa S . Patterns of occurrence of the leukaemias. Eur J Cancer. 1995; 31A(6):941-9. DOI: 10.1016/0959-8049(95)00024-0. View

12.

Broccia G, Cocco P, Casula P . Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993. Haematologica. 2001; 86(1):58-63. View

13.

Rodriguez-Abreu D, Bordoni A, Zucca E . Epidemiology of hematological malignancies. Ann Oncol. 2007; 18 Suppl 1:i3-i8. DOI: 10.1093/annonc/mdl443. View

14.

Bhurgri Y, Pervez S, Bhurgri A, Faridi N, Usman A, Kazi L . Increasing incidence of non-Hodgkin's lymphoma in Karachi, 1995-2002. Asian Pac J Cancer Prev. 2005; 6(3):364-9. View

15.

Sukpanichnant S, Sonakul D, Piankijagum A, Wanachiwanawin W, Veerakul G, Mahasandana C . Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital. Cancer. 1998; 83(6):1197-204. View

16.

Omoti C, Awodu O, Bazuaye G . Chronic lymphoid leukaemia: clinico-haematological correlation and outcome in a single institution in Niger Delta region of Nigeria. Int J Lab Hematol. 2007; 29(6):426-32. DOI: 10.1111/j.1751-553X.2007.00888.x. View

17.

Morton L, Wang S, Devesa S, Hartge P, Weisenburger D, Linet M . Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2005; 107(1):265-76. PMC: 1895348. DOI: 10.1182/blood-2005-06-2508. View

18.

Ko Y, Kim C, Park C, Jang H, Lee S, Kim S . REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised.... Cancer. 1998; 83(4):806-12. View

19.

Di Leonardo G, Torchio P, Pasqualoni E, Corrao G, Quaglino D . Incidence of malignant lymphoproliferative diseases by stage and histological variants in central Italy: a population based study 1982-1994. Eur Rev Med Pharmacol Sci. 1999; 2(2):65-74. View

20.

Cerhan J . New epidemiologic leads in the etiology of non-Hodgkin lymphoma in the elderly: the role of blood transfusion and diet. Biomed Pharmacother. 1997; 51(5):200-7. DOI: 10.1016/s0753-3322(97)81596-x. View